Prosecution Insights
Last updated: April 19, 2026

Nanjing Genscript Biotech Co. Ltd.

11 pending office actions

Portfolio Summary

11
Total Pending OAs
3
Final Rejections
8
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18401682 SAMPLE PROCESSING APPARATUS AND USE METHOD THEREFOR HAMMOND III, THOMAS M 2855 Non-Final OA Jan 01, 2024
18465964 BLENDING TUBE LEPAGE, JONATHAN EVERETT 1796 Non-Final OA Sep 12, 2023
18245114 ANTIBODIES TARGETING HUMAN CLAUDIN 18.2 AND USES THEREOF STONEBRAKER, ALYSSA RAE 1642 Non-Final OA Mar 13, 2023
18040615 ANTIBODIES AGAINST HUMAN ANGIOPOIETIN-2 AND USES THEREOF ALLEN, MARIANNE P 1647 Non-Final OA Feb 03, 2023
17998553 IMPROVED LENTIVIRAL EXPRESSION VECTOR, CONSTRUCTION METHOD FOR SAME, AND APPLICATIONS THEREOF MOORE, JOHN DAVID 1638 Non-Final OA Nov 11, 2022
17922182 CHIP SURFACE LINKER AND PREPARATION METHOD AND USE THEREFOR FANG, SHANE 1766 Non-Final OA Oct 28, 2022
17758048 Method For Constructing Gene Mutation Library FLINDERS, JEREMY C 1684 Final Rejection Jun 27, 2022
17757411 Method For Constructing A Gene Mutation Library FLINDERS, JEREMY C 1684 Non-Final OA Jun 15, 2022
17628614 ANTI-CD47/ANTI-LAG-3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF SUNSHINE, HANNAH LOUISE 1647 Final Rejection Jan 20, 2022
17624505 ANTI-CD47/ANTI-CTLA-4 BISPECIFIC ANTIBODY AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CUNNINGCHEN, KATHLEEN MARY 1646 Non-Final OA Jan 03, 2022
17617156 MONOCLONAL ANTIBODY-CYTOKINE FUSION PROTEIN DIMER AND APPLICATION THEREOF LU, CHENG 1642 Final Rejection Dec 07, 2021

Managing Nanjing Genscript Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month